Literature DB >> 15339248

Novel analogs of ghrelin: physiological and clinical implications.

Heather A Halem1, John E Taylor, Jesse Z Dong, Yeelana Shen, Rakesh Datta, Alfonso Abizaid, Sabrina Diano, Tamas Horvath, Philippe Zizzari, Marie-Thèrèse Bluet-Pajot, Jacques Epelbaum, Michael D Culler.   

Abstract

Ghrelin, the 28 amino acid peptide recently identified as the natural ligand for the growth hormone (GH) secretagogue (GHS) receptor, has multiple activities in addition to stimulation of GH secretion, including stimulation of feeding and weight gain. To utilize these actions for potential therapeutic benefit, we have produced analogs of human ghrelin with enhanced metabolic stability, affinity for the GHS receptor, and efficacy in stimulating weight gain. We have also discovered an analog of ghrelin, BIM-28163, that is an antagonist at the GHS receptor and that fully inhibits GHS receptor activation induced by native ghrelin. In vivo, BIM-28163 does not increase GH secretion but fully blocks ghrelin-induced GH secretion. In contrast, BIM-28163 acts as a full agonist with regard to the ghrelin actions of stimulating weight gain and food intake. These results suggest that a receptor other than the GHS receptor mediates the actions of ghrelin on feeding and weight gain. This concept is strengthened by our observation that at certain hypothalamic sites, BIM-28163 acts as an antagonist of ghrelin-induced neuronal activation, while at other sites, both ghrelin and BIM-28163 induce neuronal activation via the same receptor. Collectively, these results indicate the existence of a novel ghrelin receptor that may regulate the feeding activity of ghrelin. Using BIM-28163 as a tool to define the endogenous role of ghrelin in normal GH secretion, we have demonstrated that antagonism of the GHS receptor in normal rats does not impair the pulsatility of GH secretion but lowers the pulse amplitude and mean GH level. These results demonstrate that endogenous ghrelin acts to amplify the basic pattern of GH secretion established by the interplay of hypothalamic GH-releasing hormone and somatostatin. These studies demonstrate the feasibility of creating ghrelin analogs that are selective for specific activities, as well as their utility in dissecting the role of ghrelin in both normal physiology and specific pathologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339248     DOI: 10.1530/eje.0.151s071

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  20 in total

Review 1.  Bariatric surgery evolution from the malabsorptive to the hormonal era.

Authors:  Ehab Akkary
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

2.  Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.

Authors:  Céline M'Kadmi; Jean-Philippe Leyris; Lauriane Onfroy; Céline Galés; Aude Saulière; Didier Gagne; Marjorie Damian; Sophie Mary; Mathieu Maingot; Séverine Denoyelle; Pascal Verdié; Jean-Alain Fehrentz; Jean Martinez; Jean-Louis Banères; Jacky Marie
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

Review 3.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation.

Authors:  Paul J Wellman; P Shane Clifford; Juan A Rodriguez; Samuel Hughes; Carla Di Francesco; Sergio Melotto; Michela Tessari; Mauro Corsi; Angelo Bifone; Alessandro Gozzi
Journal:  Addict Biol       Date:  2011-10-21       Impact factor: 4.280

5.  Requirement of central ghrelin signaling for alcohol reward.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Sara Landgren; Nicolas Salomé; Markus Heilig; Diederik Moechars; Rakesh Datta; Daniel Perrissoud; Suzanne L Dickson; Jörgen A Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

6.  Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.

Authors:  Alfonso Abizaid; Zhong-Wu Liu; Zane B Andrews; Marya Shanabrough; Erzsebet Borok; John D Elsworth; Robert H Roth; Mark W Sleeman; Marina R Picciotto; Matthias H Tschöp; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

7.  Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors.

Authors:  P Shane Clifford; Juan Rodriguez; Destri Schul; Samuel Hughes; Tracey Kniffin; Nigel Hart; Shoshana Eitan; Luc Brunel; Jean-Alain Fehrentz; Jean Martinez; Paul J Wellman
Journal:  Addict Biol       Date:  2011-07-25       Impact factor: 4.280

Review 8.  Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

Authors:  François Chabot; Alexandre Caron; Mathieu Laplante; David H St-Pierre
Journal:  World J Diabetes       Date:  2014-06-15

9.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

10.  Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.

Authors:  Sabine Strassburg; Stefan D Anker; Tamara R Castaneda; Lukas Burget; Diego Perez-Tilve; Paul T Pfluger; Ruben Nogueiras; Heather Halem; Jesse Z Dong; Michael D Culler; Rakesh Datta; Matthias H Tschöp
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-06       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.